|$44,264||To support Grantee's efforts to advance injectable opioid treatment research in the United States.||2018 - 2020||LJAF|
|$50,000||To provide general operating support.||2017 - 2018||LJAF|
|$64,100||To support foundational work needed to conduct the first randomized controlled trial of heroin-assisted treatment for people with opioid use disorders in the United States.||2017||LJAF|
|$298,540||To support work focused on the intersection of harm reduction and substance use disorder treatment.||2019 - 2021||LJAF|
|$500,000||To support the organization's Office of Academic Engagement.||2019 - 2021||DAF|
|$500,000||To provide general operating support.||2019 - 2021||DAF|
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.